Public sector innovation and the constraints of 'platform thinking
An account of Johnson & Johnson's adenoviral vector vaccines
Datos Bibliográficos
| ID | 5658036 |
|---|---|
| Autores | Karim Sariahmed (0000-0002-1522-5267, Boston University), Janice Graham (0000-0002-6326-8122, Dalhousie University), Matthew Herder (0000-0001-5319-6199, Dalhousie University), Christopher J Morten (New York Law School) |
| Año | 2025 |
| Volumen | 387 |
| Páginas | 118687 |
| Fecha de publicación | 2025-12-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Social Science & Medicine (JOURNAL) |
| Identificadores de la revista | ISSN: 0277-9536 • E-ISSN: 1873-5347 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.socscimed.2025.118687 |
| PMID | 41125018 |
| OpenAlex | W4415507199 |
| Idioma | EN |
| Referencias citadas | 75 |
Scientists must recognize platform thinking to prevent it from unduly shaping the trajectory of biomedical research. Political and scientific leaders should invest in public-sector capacity so that promising technologies can be brought to the public without need for an industry partner in every instance
Small Worlds and Regional Innovation
From lab to mass production
“A passion to change the landscape and drive a renaissance”
How Covid‐19 vaccine supply chains emerged in the midst of a pandemic
Technology transfer, intellectual property, and the fight for the soul of WHO
‘Our project, your problem?’ A case study of the WHO’s mRNA technology transfer programme in South Africa
Global inequities in access to Covid-19 health products and technologies
Adequate trials
A precision immuno-oncology turn? Hybridizing cancer genomics and immunotherapy through neoantigens-based adoptive cell therapies
The ratio of vision to data
Rethinking Value in the Bio-economy
The social management of biomedical novelty
More-than-national and less-than-global
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |